Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis. | Bioengineering (Basel) | 2022 | 35877357 | PubTator, text mining | PubMed |
| Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer. | Curr Oncol | 2022 | 35877212 | PubTator, text mining | PubMed |
| The Role of Adipokines in Pancreatic Cancer. | Front Oncol | 2022 | 35875143 | PubTator, text mining | PubMed |
| Prostaglandin F2α and angiotensin II type 1 receptors exhibit differential cognate G protein coupling regulation. | J Biol Chem | 2022 | 35872018 | PubTator, text mining | PubMed |
| Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. | Br J Cancer | 2022 | 35869144 | PubTator, text mining | PubMed |
| Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1. | PLoS One | 2022 | 35857775 | PubTator, text mining | PubMed |
| Nanoparticle-Based Combination Therapy for Melanoma. | Front Oncol | 2022 | 35837089 | PubTator, text mining | PubMed |
| The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases. | Neuropathol Appl Neurobiol | 2022 | 35836307 | PubTator, text mining | PubMed |
| Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations. | Ophthalmology | 2022 | 35835335 | PubTator, text mining | PubMed |
| Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan. | Comput Intell Neurosci | 2022 | 35832243 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| MC4R biased signalling and the conformational basis of biological function selections. | J Cell Mol Med | 2022 | 35818295 | PubTator, text mining | PubMed |
| Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen. | Cancers (Basel) | 2022 | 35804957 | PubTator, text mining | PubMed |
| Imaging of Uveal Melanoma-Current Standard and Methods in Development. | Cancers (Basel) | 2022 | 35804919 | PubTator, text mining | PubMed |
| Cordycepin (3'-Deoxyadenosine) Suppresses Heat Shock Protein 90 Function and Targets Tumor Growth in an Adenosine Deaminase-Dependent Manner. | Cancers (Basel) | 2022 | 35804893 | PubTator, text mining | PubMed |
| The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. | Cancers (Basel) | 2022 | 35804869 | PubTator, text mining | PubMed |
| Recent Advances and Challenges in Uveal Melanoma Immunotherapy. | Cancers (Basel) | 2022 | 35804863 | PubTator, text mining | PubMed |
| GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma. | Cancers (Basel) | 2022 | 35804836 | PubTator, text mining | PubMed |
| Integrated analysis reveals the dysfunction of signaling pathways in uveal melanoma. | BMC Cancer | 2022 | 35790930 | PubTator, text mining | PubMed |
| Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection. | Commun Biol | 2022 | 35787656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=33